Investigational prostaglandin D2receptor antagonists for airway inflammation
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1080/13543784.2016.1175434
Reference87 articles.
1. Asthma phenotypes and endotypes
2. New perspectives in pharmacological treatment of mild persistent asthma
3. Immune modulation for treatment of allergic disease
4. Role of Prostaglandin D2 and Its Receptors in the Pathophysiology of Asthma
5. Prostaglandin D2 Receptors DP and CRTH2 in the Pathogenesis of Asthma
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Small molecules in the treatment of COVID-19;Signal Transduction and Targeted Therapy;2022-12-05
2. Pharmacokinetics, safety, and tolerability of TQC3564, a novel CRTh2 receptor antagonist: report of the first-in-human single- and multiple-dose escalation trials in healthy Chinese subjects;Expert Opinion on Investigational Drugs;2022-05-18
3. Building on endogenous lipid mediators to design synthetic receptor ligands;European Journal of Medicinal Chemistry;2022-03
4. A peripheral lipid sensor GPR120 remotely contributes to suppression of PGD2-microglia-provoked neuroinflammation and neurodegeneration in the mouse hippocampus;Journal of Neuroinflammation;2021-12
5. The Prostaglandin D2 Receptor CRTH2 Promotes IL-33–Induced ILC2 Accumulation in the Lung;The Journal of Immunology;2020-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3